Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀
As the COVID-19 pandemic continues to evolve, so does the landscape of vaccines developed to combat the virus. The U.S. Food and Drug Administration (FDA) has played a crucial role in this effort by approving several vaccines that employ different technologies and approaches to provide immunity against SARS-CoV-2, the virus responsible for COVID-19. These vaccines represent a critical tool in managing and mitigating the impact of the pandemic.
The table below provides a comprehensive overview of the currently FDA-approved COVID-19 vaccines.
| Vaccine Name | Type | How It Works | Target Strains | Age Group | Doses Required | Manufacturer |
|---|---|---|---|---|---|---|
| Pfizer-BioNTech (Comirnaty) | mRNA | Uses mRNA to produce the spike protein, triggering an immune response. | Original strain | 12 years and older | 2 doses, 3 weeks apart | Pfizer, BioNTech |
| Moderna | mRNA | Uses mRNA to create the viral spike protein, initiating an immune response. | Original strain | 18 years and older | 2 doses, 4 weeks apart | Moderna, Inc. |
| Johnson & Johnson (Janssen) | Viral Vector | Uses adenovirus vector to deliver spike protein gene, stimulating an immune response. | Original strain | 18 years and older | Single dose | Johnson & Johnson |
| Novavax (Nuvaxovid) | Protein Subunit | Contains spike protein pieces with an adjuvant to boost immune response. | Original strain | 18 years and older | 2 doses,... |
Try our Free Plan to get the full article.
